Stay updated on Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial
Sign up to get notified when there's something new on the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page.

Latest updates to the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page
- Check3 days agoChange DetectedResults for NCT03761914 have been posted, including ORR, PFS, and OS, along with updated enrollment figures and completion dates.SummaryDifference0.3%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange Detected- Updated version to v3.2.0 and added an important operating-status notice about funding and center operations. - Removed specific Genetic and Rare Diseases Information Center resources on Acute myeloid leukemia and Small cell lung carcinoma (v3.1.0 resources).SummaryDifference2%

- Check31 days agoChange DetectedThe page now indicates a new version (v3.1.0) and removes the topic reference 'Ovarian cancer', signaling a shift in core content and subject focus.SummaryDifference0.1%

- Check46 days agoChange DetectedMinor update: version bump v3.0.1 -> v3.0.2 with removal of 'Back to Top'. Core content remains unchanged.SummaryDifference0.1%

- Check53 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.1%

- Check60 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new medical resources and topics related to various cancers and diseases, while removing outdated or redundant information. Notably, the facility name and location details have been added, enhancing the page's relevance.SummaryDifference4%

Stay in the know with updates to Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page.